Kim Mink - Innophos Holdings CEO and President and Director
CEO
Dr. Kim Ann Mink, Ph.D. is Chairman of the Board, President, Chief Executive Officer of Innophos Holdings, Inc. She was the Chief Executive Officer and President of Innophos since December 2015, a director of Innophos since January 2016 and Chairman of the Board since February 2017. Prior to joining Innophos, she served as Business President of Elastomers, Electrical and Telecommunications at The Dow Chemical Company, or Dow Chemical, from September 2012 to December 2015. Dr. Mink joined Dow Chemical in April 2009 as Global General Manager, Performance Materials and President and Chief Executive Officer of ANGUS Chemical Co. . Prior to joining Dow Chemical, Dr. Mink was Corporationrationrate Vice President and Global General Manager, Ion Exchange Resins at the Rohm and Haas Company, where she spent more than 20 years serving in numerous senior roles with increasing responsibilities. From September 2012 to December 2015, Dr. Mink served as a member of the Board of Advisors of Catalyst Inc. From November 2012 to December 2016, she served as a member of the National Board of Trustees of the ALS Association. In addition, in 2014, Dr. Mink was named to STEMconnectors 100 Diverse Corporationrationrate Leaders in STEM. Since March 2017, Dr. Mink has served as a director of PolyOne Corporationrationration, a publiclytraded global provider of specialized polymer materials, services and solutions since 2017.
| Age | 58 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 609 495-2495 |
| Web | www.innophos.com |
Innophos Holdings Management Efficiency
Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 5 records | CEO Age | ||
| Ammar Joundi | Agnico Eagle Mines | 56 | |
| Ammar MBA | Agnico Eagle Mines | 60 | |
| Nolan Watson | Sandstorm Gold Ltd | 40 | |
| Ammar AlJoundi | Agnico Eagle Mines | 48 | |
| Anthony Makuch | Agnico Eagle Mines | 61 | |
Management Performance
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 |
Innophos Holdings Leadership Team
Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randolph Gress, Chairman, CEO and Pres | ||
| Eugenia Erlij, Vice President - Marketing | ||
| Kim Mink, CEO and President and Director | ||
| Abraham Shabot, Vice President Director General, Innophos Latin America | ||
| James Zallie, Independent Director | ||
| Peter Thomas, Director | ||
| Jean Mainente, Chief Human Resource Officer, Senior Vice President | ||
| William Dunworth, Chief Accounting Officer, Vice President Corporate Controller | ||
| Amado Cavazos, Independent Director | ||
| Nicolas Meyrial, Vice President - Commercial Nutrition | ||
| William Farran, Sr. VP, General Counsel and Member of Proxy Committee | ||
| Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development | ||
| Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis | ||
| Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S | ||
| Gary Cappeline, Lead Independent Director | ||
| Susan Turner, Vice President - Quality & Regulatory | ||
| Yasef Murat, Senior Vice President - Global Manufacturing | ||
| Hermanus Kieftenbeld, CFO, Senior Vice President | ||
| Linda Myrick, Independent Director | ||
| Amy Hartzell, Vice President - Supply Chain and Purchasing | ||
| Sherry Duff, Chief Marketing Officer, Vice President | ||
| Gail Holler, Vice President - Human Resources | ||
| Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary | ||
| Jane Hilk, Director | ||
| Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy | ||
| Robert Sklans, Chief Human Resource Officer, Senior Vice President | ||
| Joseph Golowski, Sr. VP of Global Specialty Phosphates | ||
| Charles Brodheim, Vice President Corporate Controller | ||
| Karen Osar, Independent Director | ||
| John Steitz, Independent Director | ||
| Robert Zatta, Director |
Innophos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 | |||
| Profit Margin | 0.0006 % | |||
| Operating Margin | 14.40 % | |||
| Current Valuation | 993.69 M | |||
| Shares Outstanding | 19.69 M | |||
| Shares Owned By Insiders | 1.36 % | |||
| Shares Owned By Institutions | 98.64 % | |||
| Number Of Shares Shorted | 187.27 K | |||
| Price To Earning | 29.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Innophos Stock
If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |